Trends in Cancer

Trends in Cancer is a monthly review journal published by Cell Press for Elsevier, offering concise expert commentary on frontline research and cutting-edge advances in cancer discovery and medicine, with a 2025 Journal Impact Factor of 21.6.《癌症趋势》是由（Elsevier）旗下（Cell Press）出版的月刊综述类期刊，以简洁的专家评论形式报道癌症发现与医学的前沿研究与最新进展，2025 年影响因子为 21.6。

Scope

• It publishes concise and engaging expert commentary articles that address key frontline research topics and cutting-edge advances in cancer discovery and medicine.该刊发表简洁而具吸引力的专家评论文章，聚焦癌症发现与医学领域的关键前沿主题与最新进展。
• It provides a platform for multidisciplinary information, discussion and education valuable to scientists, clinicians and policy makers, as well as to patients and advocates.该刊为科学家、临床医生与政策制定者，以及患者与倡导者，提供多学科信息、讨论与教育的平台。
• Critical issues covered include adult and pediatric cancers, personalized medicine, and the tumor microenvironment, resistance and metastasis.报道的关键议题包括成人与儿童癌症、个体化医疗，以及肿瘤微环境、耐药与转移。
• It also covers immunotherapy, metabolism, and genetics and epigenetics, along with diagnostics, biomarkers and treatment.还涵盖免疫治疗、代谢、遗传学与表观遗传学，以及诊断、生物标志物与治疗。
• Epidemiology and cancer prevention are within its scope, as are cancer-related ethics, policy and funding initiatives.流行病学与癌症预防，以及癌症相关的伦理、政策与资助议题，均属其报道范围。
• It presents and debates the opportunities, challenges and potential impact of basic, translational and clinical findings, industry research, technology and innovation in an authoritative but reader-friendly format.该刊以权威而通俗的形式呈现并讨论基础、转化与临床发现，以及产业研发、技术与创新所带来的机遇、挑战与影响。
• Its article types include reviews, mini reviews and other short commentary articles.文章类型包括综述、小型综述以及其他较短的评论文章。

History

• The journal was launched in 2015 as a new member of the Cell Press Trends review journals.该刊于 2015 年创刊，是细胞出版社（Cell Press）旗下（Trends）综述类期刊家族的新成员。
• At its founding it was the fifteenth journal in the Trends family of review journals.创刊时，它是（Trends）综述期刊家族的第 15 本期刊。
• Its founding editor was Ana Batista, who joined Cell Press in 2015 to launch the journal.其创刊编辑为 Ana Batista，她于 2015 年加入细胞出版社（Cell Press）创办该刊。
• Danielle Loughlin, who joined Cell Press in 2013 as editor of Trends in Cell Biology, became the editor of Trends in Cancer in 2020.Danielle Loughlin 于 2013 年加入细胞出版社（Cell Press）任（Trends in Cell Biology）编辑，2020 年成为《癌症趋势》编辑。
• The journal publishes twelve monthly issues each year and is indexed in the Science Citation Index Expanded.该刊每年出版 12 期月刊，并被科学引文索引扩展版（SCIE）收录。
• Among its most cited articles is a 2017 review on targeting TGF-beta signalling in cancer by Selcuk Colak and colleagues.其被引最多的文章之一是 Selcuk Colak 等人于 2017 年发表的关于靶向（TGF-β）信号通路的综述。^[1]
• A widely read 2020 review by Duan and colleagues examined how to turn immunologically cold tumors hot within the tumor microenvironment.Duan 等人 2020 年发表的一篇综述探讨了如何在肿瘤微环境中把免疫冷肿瘤转变为热肿瘤，被广泛阅读。^[2]

Editors

• Danielle Loughlin serves as the Editor-in-Chief of the journal and is based at Cell Press in Cambridge, Massachusetts.该刊主编为 Danielle Loughlin，驻（Cell Press）位于马萨诸塞州剑桥的编辑部。
• Loughlin is also the publisher of the Trends titles, a group of seventeen review journals published by Cell Press.Loughlin 同时是（Trends）系列期刊的出版人，该系列是（Cell Press）出版的 17 本综述类期刊。
• Ana Batista, who joined Cell Press in 2015 as the journal's founding editor, is listed as its Editor.Ana Batista 于 2015 年作为创刊编辑加入细胞出版社（Cell Press），现以编辑身份列于该刊。
• Editors at Cell Press handle the journal's commissioned content, and authors may raise presubmission inquiries with the editorial team.细胞出版社（Cell Press）的编辑负责该刊的邀约内容，作者可就选题意向向编辑团队进行预投稿咨询。
• Articles are peer reviewed, and the journal is listed as a member journal of the Committee on Publication Ethics.该刊文章经同行评审，并已登记为出版伦理委员会（COPE）成员期刊。